Brusniak M Y, Pearlman R S, Neve K A, Wilcox R E
Department of Veterans Affairs, VA Medical Center, Portland, Oregon 97201, USA.
J Med Chem. 1996 Feb 16;39(4):850-9. doi: 10.1021/jm950447w.
Determination of quantitative structure-activity relationship (QSAR) for affinity at particular dopamine (DA) receptors has become an even greater priority with the cloning of five DA receptor subtypes. The use of agonist affinity at recombinant receptors selectively expressed in clonal cells as the dependent variable in QSAR presents a unique opportunity for accuracy and precision in measurement of biological values. Bound conformations of 11 agonists (for which both affinity data at the recombinant D1A DA receptor and stereochemical configurations were available) were determined by alignment with a template compound, SKF38393, which shows high affinity and selectivity for D1A receptors and is fairly rigid in structure. These aligned structures suggested a 3-point pharmacophore map (one cationic nitrogen and two electronegative centers) of the D1A DA receptor. This map shows both similarities and differences when compared with a previously reported D2 DA receptor pharmacophore map based on biological data from rat brain and with a recently published map of the native D1 DA receptor using several semirigid compounds. Log(1/K(d)) values at recombinant D1A DA receptors were used as the target property for a CoMFA (comparative molecular field analysis) of the 11 aligned structures. The resulting CoMFA model yielded a cross-validated r(2)(q(2)) value of 0.829 and a simple r(2) = 0.96. In contrast, when a CoMFA model was developed for 10 of these compounds using striatal D1 K(d) values, the q(2) value was reduced to 0.178. These results are consistent with the idea that drug affinity data obtained from clonal cells expressing recombinant receptors may be superior to that obtained using heterogeneous mixtures of native receptors prepared from brain membranes. The predictive utility of the CoMFA model was evaluated using several high-affinity dopamine agonists and m- and p-tyramine, two compounds with a single hydroxyl group on the aromatic ring. Predictions were fairly accurate for all compounds but the two tyramines.
随着五种多巴胺(DA)受体亚型的克隆,确定特定DA受体亲和力的定量构效关系(QSAR)变得更加重要。在QSAR中,将克隆细胞中选择性表达的重组受体上的激动剂亲和力用作因变量,为生物值测量的准确性和精确性提供了独特的机会。通过与模板化合物SKF38393比对,确定了11种激动剂(可获得重组D1A DA受体的亲和力数据和立体化学构型)的结合构象,SKF38393对D1A受体显示出高亲和力和选择性,且结构相当刚性。这些比对结构表明了D1A DA受体的三点药效团图谱(一个阳离子氮和两个电负性中心)。与先前基于大鼠脑生物学数据报道的D2 DA受体药效团图谱以及最近使用几种半刚性化合物发表的天然D1 DA受体图谱相比,该图谱显示出异同。重组D1A DA受体处的Log(1/K(d))值用作对11种比对结构进行比较分子场分析(CoMFA)的目标属性。所得的CoMFA模型产生了交叉验证的r(2)(q(2))值为0.829,简单r(2)=0.96。相比之下,当使用纹状体D1 K(d)值为其中10种化合物建立CoMFA模型时,q(2)值降至0.178。这些结果与以下观点一致,即从表达重组受体的克隆细胞获得的药物亲和力数据可能优于使用从脑膜制备的天然受体异质混合物获得的数据。使用几种高亲和力多巴胺激动剂以及间酪氨酸和对酪氨酸(两种在芳环上具有单个羟基的化合物)评估了CoMFA模型的预测效用。除了两种酪氨酸外,对所有化合物的预测都相当准确。